Modification of acquired immunity in BALB/c mice by aztreonam

Int J Antimicrob Agents. 2000 Aug;15(3):193-9. doi: 10.1016/s0924-8579(00)00171-0.

Abstract

Recent studies have suggested that antibiotics may act as biological response modifiers. In this study we investigated the effect of aztreonam, a monobactam antibiotic, on different parameters of acquired immunity in BALB/c mice. Different dosages of aztreonam injected into mice induced an increase in the lymphoproliferative response to specific mitogens and in the production of interleukin-2 by splenic cells, as well as a decreased response of this immune population to sheep erythrocytes lower total blood cell counts and a lower percentage of monocytes than in untreated mice. These results show a modulatory action of aztreonam on different immune parameters, which is independent of its antimicrobial activity and that could be of interest in human therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody Formation / drug effects
  • Aztreonam / pharmacology*
  • Immunity / drug effects*
  • Immunity, Cellular / drug effects
  • Immunologic Factors / pharmacology*
  • Interleukin-2 / biosynthesis
  • Leukocytes, Mononuclear / immunology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Monobactams / pharmacology*
  • Spleen / immunology

Substances

  • Immunologic Factors
  • Interleukin-2
  • Monobactams
  • Aztreonam